Corporate Mergers and Acquisitions

Navigating the world of corporate mergers and acquisitions (M&A) is a cornerstone of corporate law practice and a heavily tested area on the bar exam. These transactions are not merely business deals but intricate legal processes governed by a dense framework of statutes, regulations, and fiduciary duties. Understanding this framework is essential for structuring transactions, protecting client interests, and ensuring compliance with the legal safeguards designed to balance corporate control with shareholder rights.

Fundamental Transaction Structures

The legal architecture of any M&A deal begins with selecting the acquisition method. Each structure carries distinct legal consequences for liability, tax, and the required approvals. The three primary forms are the merger, the asset purchase, and the stock purchase.

In a statutory merger, one corporation is absorbed into another, with the surviving entity inheriting all assets and liabilities by operation of law. This requires a plan of merger, approval from the boards of both companies, and, critically, a shareholder vote from both corporations (unless short-form merger rules apply). A common bar exam distinction is between a forward triangular merger, where the target merges into the acquirer’s subsidiary, and a reverse triangular merger, where the acquirer’s subsidiary merges into the target, preserving the target’s corporate shell and potentially valuable contracts or licenses.

An asset purchase involves the buyer acquiring specific assets and assuming specific liabilities of the target company. This structure allows for selectivity—the buyer can "cherry-pick" desirable assets and avoid unwanted liabilities. However, it often requires more complex documentation and may be subject to bulk sales laws. From the seller's side, an asset sale typically requires approval from the selling corporation's board and its shareholders, as it often amounts to a sale of "substantially all" of the corporation's assets under state corporate law.

A stock purchase is straightforward in concept: the buyer purchases the voting shares of the target company's shareholders, thereby obtaining control of the target as a going concern. The transaction is directly with the shareholders, not the corporate entity. A key method for accomplishing this is the tender offer, a public solicitation by the buyer (the "bidder") directed at the target's shareholders to tender their shares for sale at a specified price, often conditioned on a minimum number of shares being tendered. Tender offers are heavily regulated at the federal level by the Williams Act, which mandates disclosure and establishes procedural rules to protect shareholders.

The Legal Process: From Due Diligence to Closing

The M&A process is a meticulously staged legal journey. It begins with due diligence, a comprehensive investigation of the target company. Lawyers and financial advisers examine corporate records, material contracts, litigation risks, intellectual property, employment matters, and regulatory compliance. The goal is to uncover liabilities that could affect the purchase price, lead to post-closing indemnification claims, or even derail the deal entirely. Findings from due diligence directly feed into the negotiation of representations, warranties, and indemnification provisions in the definitive agreement.

The heart of the transaction is the merger agreement or acquisition contract. This document is the product of intense negotiation and includes critical provisions such as the purchase price and form of consideration (cash, stock, or a mix), conditions to closing (closing conditions), representations and warranties from both parties, covenants governing conduct between signing and closing, and termination rights. A pivotal clause is the material adverse change (MAC) clause, which allows the buyer to walk away if the target suffers a significant negative change in its business or prospects between signing and closing.

Corporate approval is a statutory gatekeeper. The board of directors of both companies must approve the transaction, invoking their fiduciary duties of care and loyalty. For the target company’s board, this often involves forming a special committee of independent directors and retaining financial and legal advisers to evaluate the offer's fairness. Following board approval, shareholder voting is usually required. State corporation statutes (like the Delaware General Corporation Law) mandate a shareholder vote for mergers, sales of substantially all assets, and sometimes for stock-for-stock transactions where new shares are issued. The standard is typically a majority of the outstanding shares entitled to vote, though corporate charters or bylaws may require a supermajority.

Fiduciary Duties and Shareholder Protections

The law imposes rigorous safeguards on directors and controlling shareholders during an M&A process to protect the interests of the target company's minority shareholders. The cornerstone is the business judgment rule, which presumes that directors act in good faith, on an informed basis, and in the honest belief their actions are in the corporation's best interest. However, when a company is "in play" or undergoing a change of control, this presumption can be rebutted, and enhanced scrutiny applies.

Two seminal doctrines from Delaware case law are frequently tested. The Revlon doctrine holds that when a sale of the company or a change of control becomes inevitable, the board's duty shifts from preserving the corporate entity to maximizing immediate shareholder value. The board must act as an "auctioneer" to secure the best price reasonably available. The Unocal standard applies when a board adopts defensive measures (like a "poison pill") in response to a hostile takeover. The board must demonstrate it had reasonable grounds to believe a threat to corporate policy existed and that the defensive measure adopted is proportionate to the threat.

Shareholders are afforded specific statutory rights. The right to appraisal, or dissenters' rights, allows shareholders who object to a merger to have their shares judicially appraised for fair value and be paid that amount in cash, provided they strictly follow the statutory procedural steps. Furthermore, shareholders can bring a derivative suit (on behalf of the corporation) or a direct class action if they believe directors have breached their fiduciary duties in approving a transaction, such as by failing to conduct a proper market check or by agreeing to overly restrictive deal protection devices like no-shop clauses or termination fees that may deter other bidders.

Regulatory Compliance and Antitrust Review

No M&A transaction exists in a legal vacuum; it must navigate a web of regulatory approvals. The principal antitrust law is the Hart-Scott-Rodino (HSR) Act. Parties to transactions meeting certain size-of-person and size-of-transaction thresholds must file a pre-merger notification with the Federal Trade Commission and Department of Justice, followed by a mandatory waiting period. This allows regulators to assess whether the deal may "substantially lessen competition" under Section 7 of the Clayton Act and potentially challenge it.

Beyond antitrust, transactions may require approvals from industry-specific regulators. A merger between two banks needs approval from the Federal Reserve, a telecommunications deal requires a nod from the FCC, and acquisitions involving defense contractors trigger review by the Committee on Foreign Investment in the United States (CFIUS) for national security implications. Failure to identify and secure necessary regulatory clearances is a classic closing condition that can terminate a deal.

Common Pitfalls

1. Confusing the Applicable Standard of Review: A common exam mistake is misapplying Revlon, Unocal, and the business judgment rule. Remember: Revlon applies only in the sale or change of control context. Unocal applies to defensive measures against a threat. The business judgment rule is the default for ordinary business decisions. Applying the wrong standard leads to an incorrect analysis of director liability.

1. Overlooking Procedural Requirements for Appraisal Rights: Students often forget that appraisal is not an automatic right. Shareholders must (a) not vote in favor of the merger, (b) make a written demand before the vote, and (c) strictly follow the statutory timeline for perfecting their rights. Missing a step forfeits the right to appraisal.

1. Misunderstanding the Role of the Board vs. Shareholders: It is a trap to assume shareholder approval is always required. While needed for mergers and major asset sales, many strategic decisions (like adopting a poison pill, entering a joint venture, or making a small acquisition) are within the board's sole authority under the business judgment rule. Always check the corporate statute and the company's certificate of incorporation.

1. Failing to Integrate Federal and State Law: Analysis must be two-tiered. State corporate law (fiduciary duties, voting requirements) governs the process of the transaction. Federal securities law (tender offer rules, disclosure requirements) and antitrust law (HSR filings) govern specific aspects of the transaction. A complete answer considers both layers.

Summary

• M&A transactions are structured as statutory mergers, asset purchases, or stock purchases (including via tender offers), each with distinct legal implications for liability, approval, and procedure.
• The process is governed by a definitive agreement and requires rigorous due diligence, board approval, and often a shareholder vote, all while meeting closing conditions related to regulatory clearance and the absence of a Material Adverse Change.
• Directors of the target company owe heightened fiduciary duties during a sale process, with the Revlon doctrine requiring them to maximize shareholder value in a change-of-control scenario and the Unocal standard governing the proportionality of defensive tactics.
• Key shareholder protections include the right to vote on fundamental transactions, statutory appraisal rights for dissenting shareholders, and the ability to challenge breaches of fiduciary duty through litigation.
• Regulatory compliance, particularly pre-merger antitrust notification under the Hart-Scott-Rodino Act, is a mandatory step for qualifying transactions and a critical closing condition.